Journal Articles by L. Hasikova
L. Hasikova,
P. Kozlik,
K. Kalikova,
M. Pavlíkova and
B. Stiburkova
Beyond Uric Acid: Allantoin Reflects Oxidative Stress, Disease Burden, and Cardiovascular Comorbidities in Hyperuricemia and Gout
Beyond Uric Acid: Allantoin Reflects Oxidative Stress, Disease Burden, and Cardiovascular Comorbidities in Hyperuricemia and Gout
Joint Bone Spine,
2026
L. Hasikova,
J. Zavada,
T. Serranova,
P. Kozlik,
K. Kalikova,
L. Kotackova,
J. Trnka,
D. Zogala
et al.
Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson's disease
Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson's disease
npj Parkinson's Disease,
9(1),
2023
L. Hasikova,
J. Zavada,
T. Serranova,
L. Kotackova,
P. Kozlik,
K. Kalikova,
J. Trnka,
D. Zogala
et al.
The effect of tandem coupling of NicoShell and TeicoShell columns in sub/supercritical fluid chromatography on enantioresolution
The effect of tandem coupling of NicoShell and TeicoShell columns in sub/supercritical fluid chromatography on enantioresolution
Parkinsonism & Related Disorders,
90,
2021
P. Kozlik,
L. Hasikova,
B. Stiburkova,
J. Zavada and
K. Kalikova
Rapid and reliable HILIC-MS/MS method for monitoring allantoin as a biomarker of oxidative stress
Rapid and reliable HILIC-MS/MS method for monitoring allantoin as a biomarker of oxidative stress
Analytical Biochemistry,
589,
2020
L. Hasikova,
M. Pavlikova,
H. Hulejova,
P. Kozlik,
K. Kalikova,
A. Mahajan,
M. Herrmann,
B. Stiburkova
et al.
Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3~months of treatment with TNF inhibitors
Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3~months of treatment with TNF inhibitors
Rheumatology International,
39(10),
1749-1757,
2019